C-reactive Protein Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The C-reactive protein testing market is segmented by Assay Type (Enzyme-linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay and Other Assay Types), Application, and Geography.

Market Snapshot

c reactive protein testing market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 2.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The C-reactive Protein Testing Market is expected to register a CAGR of 2.2% during the forecast period. The major factors propelling the growth of the C-reactive protein testing market include the rise in prevalence of inflammatory disorders, the increasing global incidence of endometriosis in women, rise in funding toward the technological advancement in diagnostics, and rise in the adoption of point-of-care devices.

Chronic inflammation is found to be the primary contributing factor involved in multiple chronic diseases, such as rheumatoid arthritis, lupus, ulcerative colitis, Crohn’s disease, and others. According to the Centers for Disease Control and Prevention (CDC) 2016 report, estimates that by 2040, an estimated about 78 million (26%) United States adults aged 18 years or older are projected to have doctor-diagnosed arthritis.

During the infectious state of the inflammatory disease, the CRP levels rise rapidly within the body and peak up to levels of 350–400 mg/L after 48 hours. When the inflammation decreases, the CRP levels fall, making it a highly useful marker for monitoring the activity of diseases. Therefore, a regular standardization of measurement techniques and reporting improve the utility of CRP in regular clinical practice. CRP has multiple applications within in vitro and in vivo, for the development of potential new compounds for inflammatory diseases. Thus, the rising prevalence of inflammatory diseases is among the foremost factors driving the market studied.

Furthermore, there is also an increase in funds provided to academic research institutions and individual researchers that is expected to boost the market growth. Moreover, various initiatives by international bodies, such as WHO and NIH for the prevention and treatment of chronic disorders, such as cardiovascular diseases and cancer are anticipated to promote the growth of the market.

Scope of the Report

As per the scope of the report, C-reactive protein (CRP) is one of the highly useful markers of inflammation in the body, which is produced by cells in the liver. C-reactive protein tests are the blood tests that measure the levels of C-reactive protein. These proteins are produced by the liver and its level increase when there is inflammation in the body. These tests help to identify and keep track of diseases that cause inflammation, such as certain types of cancers, cardiovascular diseases, arthritis, etc. The C-reactive Protein Testing Market is segmented by assay type, application and geography.

By Assay Type
Enzyme-linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassay (CLIA)
Immunoturbidimetric Assay
Other Assay Types
By Application
Rheumatoid Arthritis
Cardiovascular Disease
Inflammatory Bowel Disease
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East & Africa
South Africa
Rest of Middle-East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cardiovascular Disease is the Largest Segment Under Application that is Expected to Grow in the Forecast Period

Cardiovascular disorders account for the largest share in terms of adoption. Due to the high prevalence of cardiovascular diseases, there is an urgent need for developing a quick and effective method for diagnosis. So, C-reactive protein can be an indicator for the detection of CVD as there is a development of atherosclerosis, which is the laying down of cholesterol inside the blood vessel walls that create inflammation within the vessel walls. Hence, in patients suffering from CVD, there is a higher level of CRP. 

Therefore, the CRP assays to detect lower levels of CRP, which are sensitive. Hence, the high incidence rate of cardiovascular diseases is expected to encourage researchers to undertake investigational studies in CRC for cardiovascular disorders. According to the World Heart Federation, coronary heart disease is the leading cause of death worldwide. An estimated 3.8 million men and 3.4 million women die each year from coronary heart disease. In addition, 80% of the deaths occur in low- and middle-income countries. Hence owing to above all factors the cardiovascular disease segment is expected to show significant growth over the forecast period.

c protein key trend 1.png

North America has Been Reported with the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period

North America has dominated the market with the largest revenue share. The factors that are likely to be responsible for the dominance of this segment are the presence of established players, technological advancements, and well-established healthcare infrastructure. 

According to the Centers for Disease Control and Prevention, in the year 2017, coronary heart disease is the most common type of heart disease, killing approximately 365,914 people in the United States. Moreover, about 18.2 million adults age 20 and older have Coronary heart disease (CAD), 2 in 10 deaths from Coronary heart disease happen in adults less than 65 years old. Furthermore, due to effective government policies, a huge base of multinational companies, as well as high awareness among the people for testing and testing devices in healthcare, the market is expected to grow in the upcoming years.

C-reactive Protein Testing Market2

Competitive Landscape

The C-reactive Protein Testing Market is fragmented competitive. Some of the major players are seen forming strategic partnerships with other market players to expand their product portfolios. They are also looking to expand their R&D, distribution, and management facilities to gain a competitive edge in the market. Some of the companies which are currently dominating the market are Abaxis Inc (Zoetis), Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics, Randox Laboratories Ltd, Siemens Healthineers and Thermo Fisher Scientific Inc.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Prevalence of Inflammatory Disorders

      2. 4.2.2 Increasing Global Incidence of Endometriosis in Women

      3. 4.2.3 Rise in Funding toward the Technological Advancement in Diagnostics

      4. 4.2.4 Rise in the Adoption of Point-of-care Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Public Awareness

      2. 4.3.2 Availability of Alternative Treatments with Higher Accuracies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Assay Type

      1. 5.1.1 Enzyme-linked Immunosorbent Assay (ELISA)

      2. 5.1.2 Chemiluminescence Immunoassay (CLIA)

      3. 5.1.3 Immunoturbidimetric Assay

      4. 5.1.4 Other Assay Types

    2. 5.2 By Application

      1. 5.2.1 Diabetes

      2. 5.2.2 Rheumatoid Arthritis

      3. 5.2.3 Cardiovascular Disease

      4. 5.2.4 Inflammatory Bowel Disease

      5. 5.2.5 Cancer

      6. 5.2.6 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abaxis Inc. (Zoetis)

      2. 6.1.2 Abbott Laboratories

      3. 6.1.3 Beckman Coulter Inc. (Danaher Corporation)

      4. 6.1.4 F. Hoffmann-La Roche AG

      5. 6.1.5 Laboratory Corporation of America Holdings

      6. 6.1.6 Merck KGaA

      7. 6.1.7 Quest Diagnostics

      8. 6.1.8 Randox Laboratories Ltd

      9. 6.1.9 Siemens Healthineers

      10. 6.1.10 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The C-reactive Protein Testing Market market is studied from 2018 - 2026.

The C-reactive Protein Testing Market is growing at a CAGR of 2.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Abaxis Inc. (Zoetis) are the major companies operating in C-reactive Protein Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!